The Role of Norepinephrine in the Treatment of Depression


Published: September 30, 1999

Article Abstract

Despite recent strides in treatment, depression remains a common, costly, and often deadly disease, Dr. Charles B. Nemeroff stated. More than 1.2 million persons are diagnosed with an affective disorder in the United States each year, an incidence of approximately 5% to 10%, and depression is more prevalent than arthritis, diabetes, or heart disease. Depression is also a costly disease: in 1990 it was estimated that in the United States alone the cost of depression approached $44 billion, including direct costs for medication, physician services, etc., as well as indirect costs such as increased morbidity, excessive absenteeism, and reduced productivity. Depression also has a high mortality: up to 15% of severely depressed patients will ultimately commit suicide.

Volume: 60

Quick Links: Depression (MDD)

Continue Reading…

Subscribe to read the entire article


Buy this Article as a PDF

Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Frontothalamic Circuit Abnormalities in Patients With Bipolar Depression and Suicide Attempts

To identify potential markers for suicide risk, this fMRI study looked at neural activity in bipolar depression...